Skip to content

Add new IV iron review to references #1885

New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Sign up for GitHub

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Merged
alibow merged 1 commit into from
Jan 16, 2026
Merged

Add new IV iron review to references #1885

Changes from all commits
Commits
Show all changes
1 commit
Select commit
File filter

Filter by extension

Filter by extension
Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
9 changes: 7 additions & 2 deletions .../models/intervention_models/mncnh_pregnancy/iv_iron_antenatal/iv_iron_mncnh.rst
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -42,7 +42,7 @@ The antenatal IV iron intervention is intended to treat moderate and severe iron
Baseline Coverage Data
++++++++++++++++++++++++

IV iron treatment for iron-definiciency anemia pregnancy remains a relatively new intervention, and as such, coverage remains relatively low in low- and middle-income countries, such as Nigeria (see [Akinajo-et-al-2024]_).
IV iron treatment for iron-definiciency anemia pregnancy remains a relatively new intervention, and as such, coverage remains relatively low in low- and middle-income countries, such as Nigeria (see [Balogun-et-al-2026]_, [Akinajo-et-al-2024]_).
As such, we will assume a baseline coverage of 0% for all locations for the IV iron intervention.

.. note::
Expand Down Expand Up @@ -272,6 +272,10 @@ References

Akinajo, O.R., Babah, O.A., Banke-Thomas, A. et al. Acceptability of IV iron treatment for iron deficiency anaemia in pregnancy in Nigeria: a qualitative study with pregnant women, domestic decision-makers, and health care providers. Reprod Health 21, 22 (2024). https://doi.org/10.1186/s12978-024-01743-y

.. [Balogun-et-al-2026]

Balogun M, Kumah EA, Adaramoye VO, Eboreime E, Ameh C, Afolabi BB. Implementation strategies and outcomes of intravenous iron use for treatment of anaemia during and after pregnancy in low- and middle-income countries: A scoping review. PLOS Glob Public Health. 2026 Jan 9;6(1):e0004858. doi: 10.1371/journal.pgph.0004858. PMID: 41512006; PMCID: PMC12788625.

.. [Derman-et-al-2025]

Derman RJ, Bellad MB, Somannavar MS, Bhandari S, Mehta S, Mehta S, Sharma DK, Yogeshkumar S, Charantimath U, Patil AP, Mallapur AA, Ramadurg U, Sangavi R, Patil PS, Roy S, Vastrad P, Shekhar C, Leiby BE, Hartman RL, Georgieff M, Mennemeyer S, Aghai Z, Thind S, Boelig RC; RAPIDIRON Trial Group (Appendix). Single-dose intravenous iron vs oral iron for treatment of maternal iron deficiency anemia: a randomized clinical trial. Am J Obstet Gynecol. 2025 Aug;233(2):120.e1-120.e18. doi: 10.1016/j.ajog.2025.01.037. Epub 2025 Feb 3. PMID: 39909327.
Expand All @@ -282,4 +286,5 @@ References

.. [Pasricha-et-al-2025]

Pasricha, SR., Moya, E., Ataíde, R. et al. Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial. Nat Med 31, 197–206 (2025). https://doi.org/10.1038/s41591-024-03385-w
Pasricha, SR., Moya, E., Ataíde, R. et al. Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial. Nat Med 31, 197–206 (2025). https://doi.org/10.1038/s41591-024-03385-w